Physician profile
Edwin H Ryan
NPI 1093703167
$9,585,317.20
in general payments reported to CMS, 2019-2025
5 companies · $1.5M in 2025
The $1.5M reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.8M · 2020: $1.1M · 2021: $1.2M · 2022: $1.3M · 2023: $1.3M · 2024: $1.5M · 2025: $1.5M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.3M · Consulting Fee: $2,100 · Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,299,453.95 |
| Consulting Fee | $2,100.00 |
| Food and Beverage | $896.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $9,300,497.21 | 2019-2025 | Ngenuity, Unity, Constellation |
| Alcon Research LLC | $284,590.83 | 2020-2022 | |
| Dutch Ophthalmic, USA | $145.61 | 2023 | Eva, Combined Machine, Tissueblue |
| Astellas Pharma US INC | $45.55 | 2025 | Izervay |
| Alimera Sciences, INC. | $38.00 | 2023 | Iluvien |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.